Page 0039

CANCER CONTROL FRANCOPHONE 2021 37

FACTEURS DE RISQUE

46. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: a

polymicrobial disease? Nat Rev Microbiol. févr 2005;3(2):182-7.

47. Chene A, Donati D, Orem J, Mbidde ER, Kironde F, Wahlgren M, et al. Endemic

Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction

between Plasmodium falciparum and Epstein-Barr virus. Semin Cancer Biol. déc

2009;19(6):411-20.

48. Chêne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, et al. A

molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathogens.

2007;3(6):0826-34.

49. Donati D, Zhang LP, Chêne A, Chen Q, Flick K, Nyström M, et al. Identification

of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun. sept

2004;72(9):5412-8.

50. Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, Ploutz-Snyder R, et al.

Serological evidence for long-term Epstein-Barr virus reactivation in children living in a

holoendemic malaria region of Kenya. J Med Virol. juin 2009;81(6):1088-93.

51. Chattopadhyay PK, Chelimo K, Embury PB, Mulama DH, Sumba PO, Gostick E, et al.

Holoendemic Malaria Exposure Is Associated with Altered Epstein-Barr Virus-Specific

CD8+ T-Cell Differentiation. Journal of Virology. 2013;87(3):1779-88.

52. Snider CJ, Cole SR, Chelimo K, Sumba PO, Macdonald PDM, John CC, et al. Recurrent

Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity

to Epstein Barr virus lytic but not latent antigens. PLoS One. 2012;7(3):e31753.

53. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, Visintin A, et al. Malaria

hemozoin is immunologically inert but radically enhances innate responses by

presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A. 6 févr

2007;104(6):1919-24.

54. Capolunghi F, Cascioli S, Giorda E, Rosado MM, Plebani A, Auriti C, et al. CpG drives

human transitional B cells to terminal differentiation and production of natural

antibodies. J Immunol. 15 janv 2008;180(2):800-8.

55. Potup P, Kumsiri R, Kano S, Kalambaheti T, Looareesuwan S, Troye-Blomberg M,

et al. Blood stage Plasmodium falciparum antigens induce immunoglobulin class

switching in human enriched B cell culture. Southeast Asian J Trop Med Public Health. juill

2009;40(4):651-64.

56. MacNeil A, Sumba OP, Lutzke ML, Moormann A, Rochford R. Activation of the

Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer. 19

mai 2003;88(10):1566-9.

57. van den Bosch C, Griffin BE, Kazembe P, Dziweni C, Kadzamira L. Are plant factors a

missing link in the evolution of endemic Burkitt's lymphoma? British journal of cancer.

1993;68(6):1232-5.

58. Osato T, Mizuno F, Imai S, Aya T, Koizumi S, Kinoshita T, et al. African Burkitt's

lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia tirucalli. Lancet. 30

mai 1987;1(8544):1257-8.

59. Mizuno F, Osato T, Imai S, Koizumi S, Aya T, Kinoshita T, et al. Epstein-Barr virusenhancing plant promoters in east Africa. AIDS

Res. déc 1986;2 Suppl 1:S151-155.

60. Osato T, Imai S, Kinoshita T, Aya T, Sugiura M, Koizumi S, et al. Epstein-Barr

virus, Burkitt's lymphoma, and an African tumor promoter. Adv Exp Med Biol.

1990;278:147-50.

61. Ito Y, Kawanishi M, Harayama T, Takabayashi S. Combined effect of the extracts from

Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on EpsteinBarr virus expression

in human lymphoblastoid P3HR-1 and Raji cells. Cancer Lett. avr

1981;12(3):175-80.

62. Mizuno F, Koizumi S, Osato T, Kokwaro JO, Ito Y. Chinese and African Euphorbiaceae

plant extracts: Markedly enhancing effect on Epstein-Barr virus-induced

transformation. Cancer Letters. 1983;19(2):199-205.

63. Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, et al. EBV reactivation

and chromosomal polysomies: Euphorbia tirucalli as a possible cofactor in endemic

Burkitt lymphoma. Advances in Hematology. 2012;

64. Imai S, Sugiura M, Mizuno F, Ohigashi H, Koshimizu K, Chiba S, et al. African Burkitt's

lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular

immunity. Anticancer Res. juin 1994;14(3A):933-6.

65.Steel CM, Morten JE, Foster E. The cytogenetics of human B lymphoid malignancy:

studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell

lines. IARC Sci Publ. 1985;(60):265-92.

66. Aya T, Kinoshita T, Imai S, Koizumi S, Mizuno F, Osato T, et al. Chromosome

translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B

lymphocytes. Lancet. 1991;337(8751):1190.

67. Xu Y, Gong YY, Routledge MN. Aflatoxin exposure assessed by aflatoxin albumin

adduct biomarker in populations from six African countries. Vol. 11. 2018. 411-419 p.

68. Passarelli S, Bromage S, Darling AM, Wang J-S, Aboud S, Mugusi F, et al. Aflatoxin

exposure in utero and birth and growth outcomes in Tanzania. Matern Child Nutr. avr

2020;16(2):e12917.

69. Turner PC, Collinson AC, Cheung YB, Gong Y, Hall AJ, Prentice AM, et al. Aflatoxin

exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol. oct

2007;36(5):1119-25.

70. Hernandez-Vargas H, Castelino J, Silver MJ, Dominguez-Salas P, Cros MP, Durand

G, et al. Exposure to aflatoxin B1 in Utero is associated with DNA methylation in

white blood cells of infants in The Gambia. International Journal of Epidemiology.

2015;44(4):1238-48.

71. Lauer JM, Duggan CP, Ausman LM, Griffiths JK, Webb P, Wang J-S, et al. Maternal

aflatoxin exposure during pregnancy and adverse birth outcomes in Uganda. Matern

Child Nutr. avr 2019;15(2):e12701.

72. IARC IA for R on C. Monographs on the Evaluation of Carcinogenic Risks to Humans.

In: The Monographs [Internet]. 2002. p. 171-300. Disponible sur: http://monographs.

iarc.fr

73. Marchese S, Polo A, Ariano A, Velotto S, Costantini S, Severino L. Aflatoxin B1 and

M1: Biological properties and their involvement in cancer development. Vol. 10. 2018.

74. Accardi R, Gruffat H, Sirand C, Fusil F, Gheit T, Hernandez-Vargas H, et al. The

mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in

in vitro and in vivo experimental models. Carcinogenesis. nov 2015;36(11):1440-51.

75. Preisler V. Aflatoxin B1-induced mitotic recombination in L5178Y mouse lymphoma

cells. Mutagenesis. 2000;15(1):91-7.

76. International Agency for Research on Cancer. Aflatoxins IARC Monographs.

International agency for Research on Cancer. 2012;100F:225-48.

77. Rushing BR, Selim MI. Aflatoxin B1: A review on metabolism, toxicity, occurrence in

food, occupational exposure, and detoxification methods. Vol. 124. 2019. 81-100 p.

78. Engin AB, Engin A. DNA damage checkpoint response to aflatoxin B1. Vol. 65. 2019.

90-96 p.

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066
  67. Page 0067
  68. Page 0068
  69. Page 0069
  70. Page 0070
  71. Page 0071
  72. Page 0072
  73. Page 0073
  74. Page 0074
  75. Page 0075
  76. Page 0076
  77. Page 0077
  78. Page 0078
  79. Page 0079
  80. Page 0080
  81. Page 0081
  82. Page 0082
  83. Page 0083
  84. Page 0084
  85. Page 0085
  86. Page 0086
  87. Page 0087
  88. Page 0088
  89. Page 0089
  90. Page 0090
  91. Page 0091
  92. Page 0092
  93. Page 0093
  94. Page 0094
  95. Page 0095
  96. Page 0096
  97. Page 0097
  98. Page 0098
  99. Page 0099
  100. Page 0100
  101. Page 0101
  102. Page 0102
  103. Page 0103
  104. Page 0104
  105. Page 0105
  106. Page 0106
  107. Page 0107
  108. Page 0108
  109. Page 0109
  110. Page 0110
  111. Page 0111
  112. Page 0112
  113. Page 0113
  114. Page 0114
  115. Page 0115
  116. Page 0116
  117. Page 0117
  118. Page 0118
  119. Page 0119
  120. Page 0120
  121. Page 0121
  122. Page 0122